Opioid and cannabinoid receptor activation can also reduce anxiety and depressive-like phenomena, particularly through selective activation of subtypes of these classes of receptors, including the delta opioid receptor (DOR) subtype [16], [17] or cannabinoid type 1 receptor (CB1R) subtype [5], [18]–[20]. Here, CNR1 is linked to Anxiety.